NCT05332574 2022-08-05A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid TumorGenor Biopharma Co., Ltd.Phase 1/2 Unknown120 enrolled
NCT04413227 2020-06-02A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid TumorsJiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Unknown30 enrolled